{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:13:40Z","timestamp":1761016420300,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2938,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.seizure.2005.04.009","type":"journal-article","created":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T10:26:35Z","timestamp":1117621595000},"page":"362-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["No association of anti-GM1 and anti-GAD antibodies with juvenile myoclonic epilepsy: A pilot study"],"prefix":"10.1016","volume":"14","author":[{"given":"Ebru","family":"Aykutlu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bet\u00fcl","family":"Baykan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candan","family":"G\u00fcrses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fen","family":"Gokyigit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcher","family":"Saruhan-Direskeneli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2005.04.009_bib1","first-page":"368","article-title":"Juvenile myoclonic epilepsy locus in chromosome 6p21.2-p11: linkage to convulsions and electroencephalography trait","volume":"57","author":"Liu","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.seizure.2005.04.009_bib2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/hmg\/6.8.1329","article-title":"Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q","volume":"6","author":"Elmslie","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.seizure.2005.04.009_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jnnp.70.2.240","article-title":"Clinical factors of drug resistance in juvenile myoclonic epilepsy","volume":"70","author":"Gelisse","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2005.04.009_bib4","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1528-1157.1996.tb00527.x","article-title":"Cryptogenic partial epilepsies with anti-GM1 antibodies: a new form of immune-mediated epilepsy?","volume":"37","author":"Bartolomei","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.04.009_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0920-1211(00)00180-7","article-title":"Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study","volume":"42","author":"Kwan","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2005.04.009_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.55.1.46","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy","volume":"55","author":"Peltola","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2005.04.009_bib7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ana.410360419","article-title":"Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy","volume":"36","author":"Nemni","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2005.04.009_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(05)79192-3","article-title":"Temporal-lobe epilepsy associated with glutamic acid decarboxylase autoantibodies","volume":"352","author":"Giometto","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2005.04.009_bib9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/jnnp.41.5.458","article-title":"Stiff man syndrome associated with nocturnal myoclonus and epilepsy","volume":"41","author":"Martinelli","year":"1978","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2005.04.009_bib10","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM198804213181602","article-title":"Autoantibodies to glutamic acid decarboxylase in a patient with stiff man syndrome, epilepsy, type I diabetes mellitus","volume":"318","author":"Solimena","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2005.04.009_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for classification of the epilepsies and epileptic syndromes","volume":"30","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.04.009_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1528-1157.1981.tb04101.x","article-title":"An immunological model of epilepsy: seizures induced by antibodies to GM1 ganglioside","volume":"22","author":"Karpiak","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.04.009_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.982041","article-title":"Antiserum to brain gangliosides produces recurrent epileptiform activity","volume":"194","author":"Karpiak","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.seizure.2005.04.009_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jnnp.69.6.711","article-title":"Epilepsy: an autoimmune disease?","volume":"69","author":"Palace","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2005.04.009_bib15","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archneur.1997.00550220010003","article-title":"Simple partial status epilepticus and antiglycolipid IgM antibodies: possible epilepsy of autoimmune origin","volume":"54","author":"Guillon","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2005.04.009_bib16","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1073\/pnas.83.22.8808","article-title":"Monoclonal antibodies to glutamic acid decarboxylase","volume":"83","author":"Gottlieb","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.seizure.2005.04.009_bib17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng885","article-title":"Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy","volume":"31","author":"Cossette","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.seizure.2005.04.009_bib18","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0887-8994(99)00088-0","article-title":"Absence of glutamic acid decarboxylase antibodies in childhood epilepsies","volume":"21","author":"Rantala","year":"1999","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2005.04.009_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1528-1157.1990.tb05386.x","article-title":"Possible induction of systemic lupus erythematosus by valproate","volume":"31","author":"Bleck","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.04.009_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1528-1157.1994.tb02927.x","article-title":"Systemic lupus erythematosus associated with use of valproate","volume":"35","author":"Asconape","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.04.009_bib21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1528-1157.1996.tb00614.x","article-title":"Valproate-induced systemic lupus erythematosus in a patient with partial trisomy of chromosome 9 and epilepsy","volume":"37","author":"Gigli","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.04.009_bib22","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1528-1157.1999.tb02054.x","article-title":"Lupus anticoagulant induced by the combination of valproate and lamotrigine","volume":"40","author":"Echaniz-Laguna","year":"1999","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131105000841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131105000841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:33:49Z","timestamp":1761010429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131105000841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S1059131105000841"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2005.04.009","relation":{},"ISSN":["1059-1311"],"issn-type":[{"type":"print","value":"1059-1311"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No association of anti-GM1 and anti-GAD antibodies with juvenile myoclonic epilepsy: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2005.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}